跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDE SANDOZ lenalidomide 5 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
LENALIDOMIDE SANDOZ lenalidomide 5 mg capsule blister pack
Approved
STANDARD
LENALIDOMIDE SANDOZ lenalidomide 5 mg capsule blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
35869bf9d32b4e04
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
35869bf9d32b4e04
Product Name
LENALIDOMIDE SANDOZ lenalidomide 5 mg capsule blister pack
Artg Id
348791
Artg Name
LENALIDOMIDE SANDOZ lenalidomide 5 mg capsule blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2021-11-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/61b48dbcd895023ce21fba59c9e83e2b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/460ff1f5e7c98e1cdf7e669ff19eeca8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
35869bf9d32b4e04
Type
Standard
Back to TGA Approvals